Results 221 to 230 of about 762,849 (265)
Some of the next articles are maybe not open access.

Cardiac surgery in octogenarians

ANZ Journal of Surgery, 2004
Background:  Early and late results were studied in order to improve the indications for surgery in the elderly.Methods:  Two hundred and thirty‐seven patients aged 80 years or older underwent cardiac surgery between 1987 and 2001. The mean age of patients, which included 148 men and 89 women, was 82 years.
Narelle Manson   +7 more
openaire   +3 more sources

Zinc in cardiac surgery

Journal of Surgical Research, 1972
Six patients undergoing major thoracic surgical procedures were studied as controls for 28 patients who required cardiopulmonary bypass. The six thoracic surgical patients had either colon interposition or lobectomy. The pat,ients requiring cardiopulmonary bypass had various types of cardiac lesions repaired by procedures such as aortocoronary bypass ...
William J. Rea   +2 more
openaire   +2 more sources

The Economics of Cardiac Surgery

AACN Clinical Issues: Advanced Practice in Acute and Critical Care, 1993
The coronary artery bypass graft (CABG) is the most costly single surgical procedure in the United States, making bypass surgery a key target for cost containment in the current health care reform environment. This article highlights the relationship between risk factors and costs and describes some of the current initiatives aimed at cost containment ...
openaire   +3 more sources

Aprotinin in cardiac surgery

Expert Review of Cardiovascular Therapy, 2006
Aprotinin is a naturally occurring serine protease inhibitor that is being used with increasing frequency in cardiac surgery and beyond to reduce blood loss and the need for perioperative blood transfusion. Through inhibition of serine proteases such as plasmin, aprotinin significantly reduces fibrinolysis, thereby aiding hemostasis during surgical ...
Munir Boodhwani   +4 more
openaire   +3 more sources

Paediatric cardiac surgery

Scandinavian Cardiovascular Journal, 2009
We present a short discussion of the literature concerning institutional volume and outcomes for congenital heart surgery. Although there are limitations to some of the studies discussed, all published studies conclude that higher volumes are associated with better outcomes. We then reflect on some of the arguments that can be made in favour of greater
Martin Utley   +2 more
openaire   +3 more sources

ANAESTHESIA FOR CARDIAC SURGERY [PDF]

open access: possibleBritish Medical Bulletin, 1953
A. I. Parry Brown, B. A. Sellick
openaire   +4 more sources

Erythropoietin in Cardiac Surgery

Journal of Cardiac Surgery, 1993
Erythropoietin is the primary growth factor for red blood cells. A glycoprotein hormone synthesized by the kidneys, erythropoietin serves to increase red blood cell production in response to tissue hypoxia. It exerts its effect by increasing the numbers of erythroid progenitor cells in the bone marrow, and by increasing the rate at which their ...
John A. Zelano   +5 more
openaire   +3 more sources

Pediatric cardiac surgery

Current Opinion in Cardiology, 1993
Although there is fair agreement in many areas of pediatric cardiac surgery, issues of controversy and uncertainty persist. The role of the Fontan procedure in the treatment of complex congenital heart lesions is expanding, mainly by necessity, because an alternative biventricular repair is often not available.
openaire   +3 more sources

Cardiac surgery

Medical Journal of Australia, 1922
E G, Stafford, P J, Tesar
openaire   +2 more sources

Cardiac surgery and pregnancy

American Journal of Obstetrics and Gynecology, 1965
Heart disease in pregnancy. In this country the recorded incidence of heart disease in pregnancy in several large series varies from 1.2 to 3.7 per cent (Table I). In Scandinavia it appears to be significantly lower. Buemann and Kragelund,16 in 1962, found an incidence of 0.9 per cent in over 22,000 pregnancies.
openaire   +3 more sources

Home - About - Disclaimer - Privacy